Phylogica Limited Stock Profit Margin
| PH7 Stock | EUR 0.62 0.00 0.00% |
Phylogica Limited fundamentals help investors to digest information that contributes to Phylogica's financial success or failures. It also enables traders to predict the movement of Phylogica Stock. The fundamental analysis module provides a way to measure Phylogica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phylogica stock.
Phylogica |
Phylogica Limited Company Profit Margin Analysis
Phylogica's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Phylogica Limited has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all Germany stocks is 100.0% lower than that of the firm.
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Phylogica Fundamentals
| Return On Equity | -0.44 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (6.10) % | |||
| Current Valuation | 114.63 M | |||
| Shares Outstanding | 3.18 B | |||
| Shares Owned By Insiders | 59.27 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Book | 6.47 X | |||
| Price To Sales | 92.48 X | |||
| Revenue | 3.07 M | |||
| Gross Profit | 3.07 M | |||
| EBITDA | (13.42 M) | |||
| Net Income | (13.86 M) | |||
| Book Value Per Share | 0.02 X | |||
| Earnings Per Share | (0) X | |||
| Beta | 0.31 | |||
| Market Capitalization | 284.31 M | |||
| Total Asset | 45.35 M | |||
| Net Asset | 45.35 M |
About Phylogica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phylogica Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phylogica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phylogica Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Phylogica Stock Analysis
When running Phylogica's price analysis, check to measure Phylogica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phylogica is operating at the current time. Most of Phylogica's value examination focuses on studying past and present price action to predict the probability of Phylogica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phylogica's price. Additionally, you may evaluate how the addition of Phylogica to your portfolios can decrease your overall portfolio volatility.